Vimarsana
Biggest News Aggregation in the World

Page 13 - Report From News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Report From. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Report From Today - Breaking & Trending Today

Cardiovascular health technology to be fast-tracked through innovative development program - Vimarsana News

Cardiovascular health technology to be fast-tracked through innovative development program

Published: September 13, 2022

New program from the American Heart Association® and the University of California, San Francisco will speed development of health-tech innovation - New solutions for improving and managing cardiovascular health are urgently needed, but effective and worthwhile solutions often failed to make it to patients because all critical stakeholders were not involved at the right phase of the development process to ensure acceptance by patients, payers and providers along the way.

Source: heart.org
Related Topics:
United StatesSan FranciscoNancy BrownPamela KreighSam HawgoodUniversity Of CaliforniaAmerican Heart AssociationRosenman InstituteHeart Association Public InquiriesHeart HealthA Report From The American Heart AssociationToni Rembe Rock DistinguishedAmerican HeartHeart AssociationStroke StatisticsReport FromCenter For Health Technology Amp InnovationUniversity Of California San FranciscoUcsf Rosenman InstituteUcsf Rosenman Institute Build Heart Health ProgramCardiovascular HealthHealth TechnologyHealth TechCardiovascular TechnologyHealth Technology Fellowship
An Overview of Iran's History of Hostage-Taking and how Western Appeasement has Fueled Tehran's Terrorism - Vimarsana News

An Overview of Iran's History of Hostage-Taking and how Western Appeasement has Fueled Tehran's Terrorism

Published: September 6, 2022

September 2022 Prior to Iran’s 1979 revolution, all political voices were silenced by the Shah, and society suffered extensively from political ignorance.

Source: ncr-iran.org
Related Topics:
District Of ColumbiaUnited StatesNew YorkFrance GeneralBeirut International AirportMont LibanTo IranHa AfonLos AngelesWhite HouseUnited Arab EmiratesNeuilly Sur SeineCity OfUnited KingdomSaudi ArabiaNorth West FrontierAl AmalAr RiyaSouth KoreaNeve ShalomAmerican UniversityPerifereia Notiou AigaiouSouth KoreanWest GermanyAlec Collett
Amarin Corporation plc: New REDUCE-IT Data Show VASCEPA/VAZKEPA (icosapent ethyl) Reduced Cardiovascular Events in Patients Who Are Current or Former Smokers - Vimarsana News

Amarin Corporation plc: New REDUCE-IT Data Show VASCEPA/VAZKEPA (icosapent ethyl) Reduced Cardiovascular Events in Patients Who Are Current or Former Smokers

Published: August 28, 2022

-- Data Show VASCEPA/VAZKEPA Significantly Reduced First and Total Cardiovascular Events in Combined Current and Former Smokers by 23% and 29% Respectively Relative to Placebo in a Post Hoc Analysis

Source: finanznachrichten.de
Related Topics:
United StatesNew JerseyUnited KingdomUniversity Of PennsylvaniaUnited Arab EmiratesComunidad Autonoma De CatalunaGreat BritainClin CardiolColl CardiolMichael MillerJ Cardiovasc PharmacotherAmerican Heart AssociationOral Abstract At European Society Of CardiologyDrug AdministrationExchange CommissionAmarin CorporationEuropean UnionEuropean Society Of CardiologyAmarin Pharmaceuticals IrelandJournal Of The American College CardiologyHospital Of The University PennsylvaniaA Report From The American Heart AssociationReduced FirstTotal Cardiovascular EventsCombined Current
Investegate |Amarin Corporation plc Announcements | Amarin Corporation plc: New REDUCE-IT® Data Show VASCEPA®/VAZKEPA® (icosapent ethyl) Reduced STEMI as Well as Other MI Subtypes - Vimarsana News

Investegate |Amarin Corporation plc Announcements | Amarin Corporation plc: New REDUCE-IT® Data Show VASCEPA®/VAZKEPA® (icosapent ethyl) Reduced STEMI as Well as Other MI Subtypes

Published: August 26, 2022

Investegate announcements from Amarin Corporation plc, New REDUCE-IT® Data Show VASCEPA®/VAZKEPA® (icosapent ethyl) Reduced STEMI as Well as Other MI Subtypes

Source: investegate.co.uk
Related Topics:
United StatesNew JerseyUnited KingdomUnited Arab EmiratesComunidad Autonoma De CatalunaGreat BritainClin CardiolPabout AmarinDeepakl BhattAmerican Heart AssociationDrug AdministrationScience Session At European Society Of CardiologyProfessor Of Medicine At Harvard Medical SchoolExchange CommissionClinical Endpoint CommitteeAmarin CorporationJournal Of The American College CardiologyEuropean UnionEuropean Society Of CardiologyAmarin Pharmaceuticals IrelandA Report From The American Heart AssociationData ShowPost HocPresented During Late Breaking Science SessionEuropean Society
Amarin Corporation plc: New REDUCE-IT Data Show VASCEPA/VAZKEPA (icosapent ethyl) Reduced STEMI as Well as Other MI Subtypes - Vimarsana News

Amarin Corporation plc: New REDUCE-IT Data Show VASCEPA/VAZKEPA (icosapent ethyl) Reduced STEMI as Well as Other MI Subtypes

Published: August 26, 2022

-- Late-Breaking Data Show VASCEPA/VAZKEPA Significantly Reduced STEMI by 40% and NSTEMI by 27% in Pre-Specified, Post Hoc Analyses -- -- Data Presented During Late-Breaking Science Session at European

Source: finanznachrichten.de
Related Topics:
United StatesNew JerseyUnited KingdomUnited Arab EmiratesComunidad Autonoma De CatalunaGreat BritainClin CardiolColl CardiolPabout AmarinDeepakl BhattAmerican Heart AssociationDrug AdministrationScience Session At European Society Of CardiologyProfessor Of Medicine At Harvard Medical SchoolExchange CommissionClinical Endpoint CommitteeAmarin CorporationJournal Of The American College CardiologyEuropean UnionEuropean Society Of CardiologyAmarin Pharmaceuticals IrelandA Report From The American Heart AssociationBreaking Data ShowPost HocPresented During Late Breaking Science Session